|
Match
|
Document |
Document Title |
|
|
US20090312352 |
COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASE CAUSED BY YERSINIA SPP INFECTION
The invention generally relates to compositions and methods for treatment of disease caused by Yersinia spp. infection. More specifically, the invention relates to protein tyrosine phosphatase...
|
|
|
US20090253691 |
TRISUBSTITUTED 1,2,4-TRIAZOLES
The present invention relates to 3-aniline-5-aryl triazole derivatives and analogues or pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions...
|
|
|
US20090227790 |
Neuroprotective small organic molecules, compositions and uses of related thereto
The present application is directed to therapeutic compounds, compositions, and methods for culturing neuronal cells and for preventing and the treatment of neurodegenerative diseases, such as...
|
|
|
US20090215759 |
MODULATORS FOR AMYLOID BETA
The invention relates to compounds of formula
wherein the substituents are as described in claim 1 . Compounds of formula I are modulators for amyloid beta and thus, they may be useful for the...
|
|
|
US20090186895 |
ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
The present invention pertains to certain compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical...
|
|
|
US20090076282 |
3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT
To provide novel 3-triazolylphenyl sulfide derivatives having excellent soil treatment activity as insecticides, miticides or nematicides for agricultural and horticultural plants. ...
|
|
|
US20090018150 |
5-Ht2b Receptor Antagonists
Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition...
|
|
|
US20080286607 |
Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative
It is an object of the present invention to provide a novel triazole derivative. Further, it is another object of the present invention to provide a light-emitting element having high luminous...
|
|
|
US20080249115 |
Non Peptide Agonists and Antagonists of Adrenomedullin and Gastric Releasing Peptide
This invention relates, e.g., to methods for inhibiting or stimulating an activity of an adrenomedullin (AM) or gastrin releasing peptide (GRP) peptide hormone, comprising contacting the peptide...
|
|
|
US20080234252 |
Compounds Useful in Therapy
Compounds of formula (I),
or a pharmaceutically acceptable salt, solvate, ester or amide thereof, wherein
R 1 represents [CH 2 ] n —R 2 .
R 2 represents H, C 1-6 alkyloxy or Het; n...
|
|
|
US20080176840 |
Triazole compounds that modulate Hsp90 activity
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of...
|
|
|
US20080096901 |
Aminotriazole compounds useful as inhibitors of protein kinases
The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention, processes for preparing the...
|
|
|
US20080070964 |
OPIOID RECEPTOR ACTIVE COMPOUNDS
The invention provides compounds of formula I:
wherein R 1 to R 4 and n have any of the meanings defined in the specification and their pharmaceutically acceptable salts. The invention also...
|
|
|
US20080070965 |
Thiophene-carboxamides useful as inhibitors of protein kinases
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising said compounds and methods of...
|
|
|
US20080070937 |
SMALL MOLECULE INHIBITORS OF KYNURENINE-3-MONOOXYGENASE
The present invention relates to compounds of Formula I below and their tautomers or pharmaceutically acceptable salts, compositions and methods of uses thereof.
|